Rapamycin increases the incidence of neuropsychiatric illness in kidney transplant patients through the suppression of neural stem cells

Rapamycin inhibits protein translation in cells, including neural stem cells (NSCs), by suppressing the mechanistic target of rapamycin (mTOR). This drug has been widely used together with calcineurin inhibitors in transplantation patients to prevent graft rejection. Previous studies have reported a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yangsik, Lee, Jung Sun, Joo, Yeon Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235015/
https://www.ncbi.nlm.nih.gov/pubmed/32424120
http://dx.doi.org/10.1038/s41398-020-0838-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235015/
https://www.ncbi.nlm.nih.gov/pubmed/32424120
http://dx.doi.org/10.1038/s41398-020-0838-2

Ejemplares similares